On Wednesday, the Department of Health and Human Services released a plan to lower drug prices, which includes allowing Medicare to negotiate lower prices, extending negotiated prices to the private…
News Sep 13, 2021Signaling that patient advocates and employers are on the same page when it comes to prescription drug price reform, Patients For Affordable Drugs Now and Purchaser Business Group on Health (PBGH)…
Press Releases Sep 9, 2021The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, in response to the release today of the Biden administration’s Comprehensive…
Press Releases Sep 9, 2021Patients For Affordable Drugs Now announced it is launching a new phase of its campaign today to combat recent Big Pharma lies and scare tactics.
News Sep 7, 2021On Monday, P4ADNow released a video featuring founder David Mitchell setting the record straight on how Medicare negotiation would improve access to drugs, contrary to Big Pharma’s lies that patient…
News Aug 31, 2021Patients For Affordable Drugs Now released a new video that exposes how Big Pharma’s recent multi-million dollar ad campaigns are full of lies about how Medicare negotiation would limit access to drugs.
News Aug 30, 2021This week, P4AD released a fact check breaking down six misleading claims found in pharma-funded ads, including falsehoods about the non-interference clause and the impact of Medicare negotiation.
Press Releases Aug 27, 2021The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, in response to the Congressional Budget Office’s Simulation of New Drug Development:
News Aug 23, 2021Building on two national ads launched last weekend, P4ADNow launched a seven-figure ad buy on Tuesday thanking representatives across 12 House districts for supporting Medicare negotiation.
Press Releases Aug 17, 2021Patients For Affordable Drugs Now launched a seven-figure ad buy today across 12 House districts thanking representatives for supporting proposals to lower drug prices by allowing Medicare negotiation.